CannaPharmaRX, Inc.
CPMD
$0.00
$0.002.70%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.36M | 1.71M | 1.36M | 1.13M | 820.10K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.36M | 1.71M | 1.36M | 1.13M | 820.10K |
| Cost of Revenue | 3.75M | 4.96M | 4.53M | 3.85M | 3.76M |
| Gross Profit | -2.39M | -3.25M | -3.17M | -2.72M | -2.94M |
| SG&A Expenses | 893.80K | 749.10K | 413.30K | 531.30K | 695.90K |
| Depreciation & Amortization | -- | -87.30K | -87.30K | -23.10K | -100.00 |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.64M | 5.62M | 4.86M | 4.36M | 4.45M |
| Operating Income | -3.28M | -3.92M | -3.50M | -3.23M | -3.63M |
| Income Before Tax | -11.13M | -7.32M | -5.66M | 1.12M | -9.91M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -11.13 | -7.32 | -5.66 | 1.12 | -9.91 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -11.13M | -7.32M | -5.66M | 1.12M | -9.91M |
| EBIT | -3.28M | -3.92M | -3.50M | -3.23M | -3.63M |
| EBITDA | -1.45M | -2.98M | -3.50M | -3.17M | -3.54M |
| EPS Basic | -0.02 | -0.01 | -0.01 | 0.00 | -0.03 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | 0.00 | -0.02 |
| EPS Diluted | -0.02 | -0.01 | -0.01 | 0.00 | -0.03 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | 0.00 | -0.02 |
| Average Basic Shares Outstanding | 2.65B | 2.65B | 2.65B | 2.65B | 2.33B |
| Average Diluted Shares Outstanding | 2.65B | 2.65B | 2.65B | 2.65B | 2.33B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |